I've been lightly keeping tabs on NYR. Good to see trial can kick off in a few months time.
Seth Gordon coming on board for this trial looks like a big green flag. Very high calibre operator by the look of things - Columbia MBA, senior Pharma guy, and senior roles in pharma consulting firms.
Ann: Cholesterol-Lowering Program Preclinical Development Update, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.035(10.0%) |
Mkt cap ! $68.54M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 31.0¢ | $118.1K | 364.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 87179 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 48809 | 3 |
View Market Depth
| Last trade - 13.28pm 22/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |